TrialDiabetes, obesity & metabolism2016

Sodium-glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low-carbohydrate diet.

R Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.